Total Payments
$440.20
2023 Payments
$55.65
Companies
13
Transactions
31
Medicare Patients
819
Medicare Billing
$50,343
Payment Breakdown by Category
Food & Beverage$440.20 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $440.20 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $146.16 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $66.45 | 5 | $0 (2017) |
| Novo Nordisk Inc | $45.65 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $29.79 | 2 | $0 (2017) |
| PFIZER INC. | $27.09 | 2 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $20.38 | 1 | $0 (2023) |
| Genentech USA, Inc. | $17.40 | 1 | $0 (2021) |
| ABBVIE INC. | $17.38 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $16.84 | 1 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $14.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $55.65 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($20.38) |
| 2021 | $30.62 | 2 | Genentech USA, Inc. ($17.40) |
| 2020 | $11.57 | 1 | Astellas Pharma US Inc ($11.57) |
| 2018 | $41.16 | 3 | Astellas Pharma US Inc ($41.16) |
| 2017 | $301.20 | 22 | Astellas Pharma US Inc ($80.21) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Cardio-renal | ||||||
| 02/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Obesity | ||||||
| 02/25/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: UROLOGY | ||||||
| 01/22/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Virology & Specialty Care | ||||||
| 03/10/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: UROLOGY | ||||||
| 07/26/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: UROLOGY | ||||||
| 05/02/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: UROLOGY | ||||||
| 02/28/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: UROLOGY | ||||||
| 12/29/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Urology | ||||||
| 10/17/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: VACCINES | ||||||
| 09/26/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Urology | ||||||
| 08/09/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/01/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Urology | ||||||
| 06/22/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Urology | ||||||
| 06/20/2017 | AstraZeneca Pharmaceuticals LP | SYNAGIS (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Respiratory | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/07/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/24/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: DIABETES | ||||||
| 05/18/2017 | PFIZER INC. | EUCRISA (Drug), CHANTIX, LYRICA | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: DERMATOLOGY | ||||||
| 04/26/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 04/12/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: DIABETES | ||||||
| 04/04/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/28/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Urology | ||||||
| 02/22/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 127 | 127 | $20,915 | $7,245 |
| 2022 | 8 | 214 | 217 | $39,044 | $14,833 |
| 2021 | 8 | 284 | 287 | $44,000 | $17,906 |
| 2020 | 6 | 194 | 198 | $30,183 | $10,360 |
Total Patients
819
Total Services
829
Medicare Billing
$50,343
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 22 | $4,554 | $1,703 | 37.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 28 | 28 | $2,856 | $1,408 | 49.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,620 | $1,402 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,648 | $1,380 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 29 | $3,915 | $1,321 | 33.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $322.00 | $30.80 | 9.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $12,936 | $4,062 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 51 | $6,885 | $3,038 | 44.1% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 16 | 16 | $5,632 | $2,244 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,308 | $2,224 | 35.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 34 | 34 | $3,468 | $1,714 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $2,691 | $1,235 | 45.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 15 | $825.00 | $287.62 | 34.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 13 | $299.00 | $28.76 | 9.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 80 | 80 | $8,160 | $4,105 | 50.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 49 | 49 | $11,319 | $3,703 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 47 | $6,345 | $3,011 | 47.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $6,972 | $2,420 | 34.7% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 30 | 30 | $4,770 | $1,829 | 38.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $3,726 | $1,804 | 48.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 23 | $2,271 | $990.74 | 43.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 19 | $437.00 | $42.75 | 9.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 56 | 56 | $12,936 | $3,869 | 29.9% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 43 | 43 | $4,386 | $2,206 | 50.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 32 | $4,320 | $1,665 | 38.5% |
About Dr. Hillary Hunt, MD
Dr. Hillary Hunt, MD is a Internal Medicine healthcare provider based in Smyrna, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124238951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hillary Hunt, MD has received a total of $440.20 in payments from pharmaceutical and medical device companies, with $55.65 received in 2023. These payments were reported across 31 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($440.20).
As a Medicare-enrolled provider, Hunt has provided services to 819 Medicare beneficiaries, totaling 829 services with total Medicare billing of $50,343. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics, Internal Medicine
- Location Smyrna, TN
- Active Since 05/23/2007
- Last Updated 08/10/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124238951
Products in Payments
- Myrbetriq (Drug) $80.21
- JANUVIA (Drug) $50.26
- MYRBETRIQ (Drug) $38.51
- TOUJEO (Drug) $29.79
- Victoza (Drug) $27.76
- VESICARE (Drug) $27.44
- Kerendia (Drug) $20.38
- Wegovy (Drug) $17.89
- Xofluza (Drug) $17.40
- VRAYLAR (Drug) $17.38
- XARELTO (Drug) $16.84
- ZOSTAVAX (Biological) $16.19
- ADVANTAGE FIT SYSTEM (Device) $14.93
- EUCRISA (Drug) $14.72
- SPIRIVA (Drug) $13.64
- SYNAGIS (Biological) $12.43
- PREVNAR - 13 (Biological) $12.37
- ADVAIR (Drug) $12.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Smyrna
Michael Gibson, M.d, M.D
Internal Medicine — Payments: $2.0M
Internal Medicine $2.0M
Hammad Aziz, M.d, M.D
Internal Medicine — Payments: $13,225
Internal Medicine $13,225
Mr. Islam Al Junaidi, Md, MD
Internal Medicine — Payments: $10,247
Internal Medicine $10,247
Dr. Sara Owen, Md, MD
Internal Medicine — Payments: $7,990
Internal Medicine $7,990
Michaele Brown, M.d, M.D
Internal Medicine — Payments: $6,002
Internal Medicine $6,002
Dr. Matthew Perkins, Md, MD
Internal Medicine — Payments: $5,240
Internal Medicine $5,240